Germany
Japan
United Kingdom
China
ALK mouse monoclonal antibody, clone OTI1A4
| Applications | IHC, LMNX, WB |
| Reactivities | Human, Mouse, Rat |
| Conjugation | Unconjugated |
Antibodies
Download
.jpg?d=110x100 "User supplied image")
Rabbit monoclonal anti-CHK1 antibody for SISCAPA, clone OTIR3G7
| Applications | SISCAPA |
| Reactivities | Human, Mouse, Rat |
| Conjugation | Unconjugated |
Rabbit monoclonal anti-ERK3 antibody for SISCAPA, clone OTIR5F3
| Applications | SISCAPA |
| Reactivities | Human, Mouse, Rat |
| Conjugation | Unconjugated |
Rabbit polyclonal Bi-Phospho-ERK1/2(T202/Y204) Antibody
| Applications | Dot, WB |
| Reactivities | Human |
| Conjugation | Unconjugated |
| Immunogen | This ERK1/2 Antibody is generated from rabbits immunized with a KLH conjugated synthetic phosphopeptide corresponding to amino acid residues surrounding T202/Y204 of human ERK1/2. |
| Modifications | Phospho-specific |
HER2 (ERBB2) Mouse Monoclonal Antibody, clone 3C2-4
| Applications | FC |
| Reactivities | Human, Mouse, Rat |
| Conjugation | Unconjugated |
HER2 (ERBB2) Mouse Monoclonal Antibody, clone 3G11-14
| Applications | FC |
| Reactivities | Human, Mouse, Rat |
| Conjugation | Unconjugated |
HER2 (ERBB2) Mouse Monoclonal Antibody, clone 4A5-19
| Applications | FC |
| Reactivities | Human, Mouse, Rat |
| Conjugation | Unconjugated |
HER2 (ERBB2) Mouse Monoclonal Antibody, clone 5F4-15
| Applications | FC |
| Reactivities | Human, Mouse, Rat |
| Conjugation | Unconjugated |
HER2 (ERBB2) Mouse Monoclonal Antibody, clone 5G12-21
| Applications | FC |
| Reactivities | Human, Mouse, Rat |
| Conjugation | Unconjugated |
HER2 (ERBB2) Mouse Monoclonal Antibody, clone 6F5-23
| Applications | FC |
| Reactivities | Human, Mouse, Rat |
| Conjugation | Unconjugated |
HER2 (ERBB2) Mouse Monoclonal Antibody, clone 6H8-22
| Applications | FC |
| Reactivities | Human, Mouse, Rat |
| Conjugation | Unconjugated |
HER2 (ERBB2) Mouse Monoclonal Antibody, clone 8E8-2
| Applications | FC |
| Reactivities | Human, Mouse, Rat |
| Conjugation | Unconjugated |
HER2 (ERBB2) Mouse Monoclonal Antibody, clone 8F6-6
| Applications | FC |
| Reactivities | Human, Mouse, Rat |
| Conjugation | Unconjugated |
HER2 (ERBB2) Mouse Monoclonal Antibody, clone 9G5-20
| Applications | FC |
| Reactivities | Human, Mouse, Rat |
| Conjugation | Unconjugated |
HER2 (ERBB2) Mouse Monoclonal Antibody, clone 12G4-15
| Applications | FC |
| Reactivities | Human, Mouse, Rat |
| Conjugation | Unconjugated |
HER2 (ERBB2) Mouse Monoclonal Antibody, clone 15C4-8
| Applications | FC |
| Reactivities | Human, Mouse, Rat |
| Conjugation | Unconjugated |
HER2 (ERBB2) Mouse Monoclonal Antibody, clone 16F12-11
| Applications | FC |
| Reactivities | Human, Mouse, Rat |
| Conjugation | Unconjugated |
Rabbit anti-VEGFR (Phospho-Tyr951) polyclonal antibody (Phospho-specific)
| Applications | IHC, WB |
| Reactivities | Human, Mouse, Rat |
| Conjugation | Unconjugated |
| Immunogen | The antiserum was produced against synthesized phosphopeptide derived from humanVEGFR2 around the phosphorylation site of tyrosine 951 (K-D-YP-V-G). |
| Modifications | Phospho-specific |
Mouse Monoclonal anti-Syk Antibody
| Applications | WB |
| Reactivities | Mouse |
| Conjugation | Unconjugated |
Goat Polyclonal Anti-VEGFR2 Antibody
| Applications | WB |
| Reactivities | Canine, Human, Mouse |
| Conjugation | Unconjugated |
| Immunogen | Purified recombinant peptide derived from the N-terminus (residues 20-125 aa) of human VEGFR2 produced in E. coli. |
BLK Rabbit Polyclonal Antibody
| Applications | IF, IHC, WB |
| Reactivities | Human, Mouse |
| Conjugation | Unconjugated |
| Immunogen | This BLK antibody is generated from rabbits immunized with a KLH conjugated synthetic peptide between 1-30 amino acids from the N-terminal region of human BLK. |
Rabbit polyclonal RIPK2 (Ser176) antibody(Phospho-specific)
| Applications | IHC, WB |
| Reactivities | Human, Mouse |
| Conjugation | Unconjugated |
| Immunogen | The antiserum was produced against synthesized phosphopeptide derived from human RIPK2 around the phosphorylation site of serine 176 (S-L-SP-Q-S). |
| Modifications | Phospho-specific |
Rabbit Polyclonal ZIPK Antibody
| Applications | IF, WB |
| Reactivities | Human, Mouse, Rat |
| Conjugation | Unconjugated |
| Immunogen | ZIP kinase antibody was raised against a peptide corresponding to amino acids near the center of human ZIP kinase. The immunogen is located within amino acids 270 - 320 of ZIPK. |
Rabbit Polyclonal antibody to CaMKII delta (calcium/calmodulin-dependent protein kinase II delta)
| Applications | IF, WB |
| Reactivities | Human, Mouse |
| Conjugation | Unconjugated |
| Immunogen | Recombinant fragment contain a sequence corresponding to a region within amino acids 249 and 445 of CaMK2D (Uniprot ID#Q13557) |
Rabbit polyclonal TGFBR2 (Ab-250) antibody
| Applications | IHC, WB |
| Reactivities | Human, Mouse |
| Conjugation | Unconjugated |
| Immunogen | The antiserum was produced against synthesized non-phosphopeptide derived from human TGFBR2 around the phosphorylation site of serine 250 (D-R-SP-D-I). |
Rabbit Polyclonal antibody to Activin A Receptor type IIA (activin A receptor, type IIA)
| Applications | WB |
| Reactivities | Human |
| Conjugation | Unconjugated |
| Immunogen | Recombinant fragment corresponding to a region within amino acids 267 and 513 of Activin A Receptor type IIA (Uniprot ID#P27037) |
Rabbit polyclonal CaMKII (Thr305) antibody(Phospho-specific)
| Applications | IHC, WB |
| Reactivities | Human, Mouse, Rat |
| Conjugation | Unconjugated |
| Immunogen | The antiserum was produced against synthesized phosphopeptide derived from human CaMKII around the phosphorylation site of threonine 305 (I-L-TP-T-M). |
| Modifications | Phospho-specific |
Active filters
Families
- Protein Kinase
Availabilities
- In Stock
Filter by
Target Symbol
- ALK (114)
- ERBB2 (107)
- MAP2K1 (86)
- EGFR (73)
- MAP2K3 (62)
- BRAF (44)
- MAPK13 (39)
- AKT1 (35)
- FGFR2 (35)
- KIT (31)
- MTOR (30)
- RET (25)
- MET (24)
- ERBB3 (23)
- RIPK3 (23)
- PDGFRB (22)
- MAPK1 (21)
- PDGFRA (21)
- MAPKAPK5 (20)
- CHEK2 (19)
- CSNK1G1 (19)
- RPS6KA2 (19)
- BTK (18)
- CDK2 (18)
- CSNK1G2 (18)
- FGFR1 (18)
- AKT2 (17)
- LIMK1 (17)
- MARK3 (17)
- POMK (16)
- TLK2 (16)
- TRIM24 (16)
- BUB1B (15)
- MAP2K4 (15)
- PLK4 (15)
- PRKCE (15)
- PTK2 (15)
- RPS6KB1 (15)
- JAK2 (14)
- ROR2 (14)
- STK39 (14)
- TYRO3 (14)
- CAMK2B (13)
- CHEK1 (13)
- HIPK1 (13)
- KDR (13)
- MAK (13)
- RIPK1 (13)
- TWF1 (13)
- IGF1R (12)
- MAP2K2 (12)
- MAPK14 (12)
- MAPK7 (12)
- MAPK8 (12)
- PLK1 (12)
- ROS1 (12)
- TRIB3 (12)
- CDKL1 (11)
- CDKL2 (11)
- IKBKE (11)
- MAPK9 (11)
- PRKCD (11)
- SRC (11)
- STK11 (11)
- ERBB4 (10)
- MAST2 (10)
- PAK1 (10)
- PRKCA (10)
- PRKD2 (10)
- RAF1 (10)
- RIOK2 (10)
- TP53RK (10)
- TRIB1 (10)
- ARAF (9)
- CSNK1E (9)
- FRK (9)
- IRAK2 (9)
- MAP3K8 (9)
- MAPK3 (9)
- NRBP1 (9)
- PIM2 (9)
- SYK (9)
- ACVR2A (8)
- AURKC (8)
- CHUK (8)
- CSF1R (8)
- GSK3A (8)
- MOK (8)
- PRKY (8)
- ABL1 (7)
- CAMK2A (7)
- CDK15 (7)
- EPHA2 (7)
- FGFR3 (7)
- FLT4 (7)
- MAP3K7 (7)
- NTRK1 (7)
- NTRK2 (7)
- PHKG2 (7)
- RPS6KA5 (7)
Reactivities
Applications
Antibody Hosts
Isotypes
Clonalities
Conjugates
Knockout (KO) Validation
Modifications
Assay Types
Assay Platforms
Pathways
- Pathways in cancer (802)
- MAPK signaling pathway (785)
- ErbB signaling pathway (655)
- Focal adhesion (628)
- Prostate cancer (602)
- Pancreatic cancer (475)
- Neurotrophin signaling pathway (465)
- GnRH signaling pathway (463)
- Non-small cell lung cancer (448)
- Glioma (445)
- Regulation of actin cytoskeleton (441)
- Endometrial cancer (436)
- Fc epsilon RI signaling pathway (436)
- Colorectal cancer (430)
- Melanoma (419)
- Progesterone-mediated oocyte maturation (409)
- Toll-like receptor signaling pathway (408)
- Bladder cancer (393)
- Insulin signaling pathway (373)
- Acute myeloid leukemia (357)
- Chemokine signaling pathway (346)
- T cell receptor signaling pathway (336)
- Endocytosis (334)
- Gap junction (319)
- Calcium signaling pathway (317)
- Adherens junction (309)
- VEGF signaling pathway (309)
- Renal cell carcinoma (299)
- Fc gamma R-mediated phagocytosis (288)
- Chronic myeloid leukemia (287)
- Long-term potentiation (264)
- Vascular smooth muscle contraction (259)
- B cell receptor signaling pathway (243)
- Epithelial cell signaling in Helicobacter pylori infection (236)
- Natural killer cell mediated cytotoxicity (236)
- Oocyte meiosis (236)
- Cytokine-cytokine receptor interaction (235)
- Long-term depression (231)
- mTOR signaling pathway (227)
- Melanogenesis (216)
- Thyroid cancer (204)
- Dorso-ventral axis formation (189)
- Axon guidance (176)
- Adipocytokine signaling pathway (165)
- Prion diseases (140)
- NOD-like receptor signaling pathway (136)
- RIG-I-like receptor signaling pathway (130)
- Type II diabetes mellitus (130)
- Amyotrophic lateral sclerosis (ALS) (127)
- Tight junction (122)
- Apoptosis (112)
- Cell cycle (110)
- Wnt signaling pathway (108)
- Small cell lung cancer (105)
- Leukocyte transendothelial migration (95)
- TGF-beta signaling pathway (89)
- Jak-STAT signaling pathway (78)
- Hedgehog signaling pathway (62)
- Cytosolic DNA-sensing pathway (61)
- p53 signaling pathway (58)
- Hematopoietic cell lineage (43)
- Alzheimer's disease (41)
- Olfactory transduction (41)
- Pathogenic Escherichia coli infection (27)
- Primary immunodeficiency (24)
- Vibrio cholerae infection (24)
- Phosphatidylinositol signaling system (16)
- Viral myocarditis (12)
- Regulation of autophagy (11)
- Circadian rhythm - mammal (10)
- Dilated cardiomyopathy (8)
- Taste transduction (8)
- Hypertrophic cardiomyopathy (HCM) (7)
- PPAR signaling pathway (7)
- Ubiquitin mediated proteolysis (6)
- Purine metabolism (4)
- Basal cell carcinoma (3)
- Parkinson's disease (3)
- Basal transcription factors (2)
- Non-homologous end-joining (2)